Australia Corticosteroid Market (2026-2032) Outlook | Growth, Trends, Companies, Share, Industry, Size, Forecast, Analysis, Revenue & Value

Market Forecast By Product (Glucocorticoids, Mineralocorticoids), By Administration (Topical Steroids, Inhaled Steroids, Oral Forms, Systemic Forms, Others), By Application (Rheumatology Indications, Skin Allergies, Endocrinology, Gastroenterology, Acute Respiratory Diseases, Others) And Competitive Landscape
Product Code: ETC320735 Publication Date: Aug 2022 Updated Date: Feb 2026 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Padhi No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Australia Corticosteroid Market: Import Trend Analysis

Australia`s import trend for the corticosteroid market showed significant growth from 2023 to 2024, with a growth rate of 94.29%. However, the compound annual growth rate (CAGR) for the period of 2020 to 2024 was -21.08%. This decline may be attributed to shifts in demand dynamics or changes in trade policies impacting market stability.

 Australia Corticosteroid Market: Import Trend Analysis

Australia Corticosteroid Market Overview

The Australia Corticosteroid market is a significant segment within the pharmaceutical industry, catering to various medical conditions such as asthma, allergies, rheumatoid arthritis, and skin disorders. Corticosteroids are commonly prescribed medications due to their potent anti-inflammatory and immunosuppressive properties. Factors driving market growth include the increasing prevalence of chronic diseases, rising geriatric population, and advancements in drug delivery technologies. Additionally, the growing awareness about corticosteroid therapies and their effectiveness in managing inflammatory conditions contributes to market expansion.

Drivers of the market

The Australia Corticosteroid market is being driven by several factors. One significant driver is the increasing prevalence of inflammatory and autoimmune diseases such as asthma, rheumatoid arthritis, and inflammatory bowel disease. Corticosteroids are commonly prescribed for the management of these conditions due to their potent anti-inflammatory properties. Additionally, the aging population in Australia is contributing to market growth as older individuals are more prone to conditions that require corticosteroid treatment, such as osteoarthritis and chronic obstructive pulmonary disease (COPD). Moreover, advancements in drug delivery technology, such as the development of novel formulations and delivery methods, are expanding the market by improving patient compliance and treatment outcomes.

Challenges of the market

Despite the growth potential, the Australia Corticosteroid Market faces several challenges. One significant challenge is the increasing scrutiny and regulation surrounding the use of corticosteroids due to their potential side effects and misuse. Regulatory changes and stricter guidelines for prescribing corticosteroids can impact market dynamics and limit growth opportunities. Additionally, competition from alternative treatments and therapies, such as non-steroidal anti-inflammatory drugs (NSAIDs) and biologics, poses a challenge to the corticosteroid market. Moreover, pricing pressures and reimbursement issues may also hinder market growth in Australia.

Government Policy of the market

The Australia government has implemented various policies and regulations to govern the corticosteroid market. These policies typically revolve around drug safety, efficacy, and accessibility. Regulatory bodies such as the Therapeutic Goods Administration (TGA) oversee the registration, manufacturing, importation, and distribution of corticosteroid medications in Australia. They ensure that these drugs meet strict quality standards and adhere to labeling requirements. Additionally, government policies may focus on promoting research and development in corticosteroid therapies, fostering innovation, and ensuring affordable access to these medications for patients across the country.

Key Highlights of the Report:

  • Australia Corticosteroid Market Outlook
  • Market Size of Australia Corticosteroid Market, 2025
  • Forecast of Australia Corticosteroid Market, 2032
  • Historical Data and Forecast of Australia Corticosteroid Revenues & Volume for the Period 2022-2032F
  • Australia Corticosteroid Market Trend Evolution
  • Australia Corticosteroid Market Drivers and Challenges
  • Australia Corticosteroid Price Trends
  • Australia Corticosteroid Porter's Five Forces
  • Australia Corticosteroid Industry Life Cycle
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Product for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Glucocorticoids for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Mineralocorticoids for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Administration for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Topical Steroids for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Inhaled Steroids for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Oral Forms for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Systemic Forms for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Others for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Application for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Rheumatology Indications for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Skin Allergies for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Endocrinology for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Gastroenterology for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Acute Respiratory Diseases for the Period 2022-2032F
  • Historical Data and Forecast of Australia Corticosteroid Market Revenues & Volume By Others for the Period 2022-2032F
  • Australia Corticosteroid Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Administration
  • Market Opportunity Assessment By Application
  • Australia Corticosteroid Top Companies Market Share
  • Australia Corticosteroid Competitive Benchmarking By Technical and Operational Parameters
  • Australia Corticosteroid Company Profiles
  • Australia Corticosteroid Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Australia Corticosteroid Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Australia Corticosteroid Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Australia Corticosteroid Market Overview

3.1 Australia Country Macro Economic Indicators

3.2 Australia Corticosteroid Market Revenues & Volume, 2022 & 2032F

3.3 Australia Corticosteroid Market - Industry Life Cycle

3.4 Australia Corticosteroid Market - Porter's Five Forces

3.5 Australia Corticosteroid Market Revenues & Volume Share, By Product, 2022 & 2032F

3.6 Australia Corticosteroid Market Revenues & Volume Share, By Administration, 2022 & 2032F

3.7 Australia Corticosteroid Market Revenues & Volume Share, By Application, 2022 & 2032F

4 Australia Corticosteroid Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases such as asthma, arthritis, and dermatitis requiring corticosteroid treatments

4.2.2 Growing geriatric population in Australia leading to higher demand for corticosteroids

4.2.3 Technological advancements in drug delivery methods improving effectiveness and patient compliance

4.3 Market Restraints

4.3.1 Stringent regulations and approval processes for corticosteroid medications limiting market entry for new players

4.3.2 Rising concerns over potential side effects and long-term health risks associated with corticosteroid use

4.3.3 Competition from alternative treatment options such as non-steroidal anti-inflammatory drugs (NSAIDs) and biologics

5 Australia Corticosteroid Market Trends

6 Australia Corticosteroid Market, By Types

6.1 Australia Corticosteroid Market, By Product

6.1.1 Overview and Analysis

6.1.2 Australia Corticosteroid Market Revenues & Volume, By Product, 2022-2032F

6.1.3 Australia Corticosteroid Market Revenues & Volume, By Glucocorticoids, 2022-2032F

6.1.4 Australia Corticosteroid Market Revenues & Volume, By Mineralocorticoids, 2022-2032F

6.2 Australia Corticosteroid Market, By Administration

6.2.1 Overview and Analysis

6.2.2 Australia Corticosteroid Market Revenues & Volume, By Topical Steroids, 2022-2032F

6.2.3 Australia Corticosteroid Market Revenues & Volume, By Inhaled Steroids, 2022-2032F

6.2.4 Australia Corticosteroid Market Revenues & Volume, By Oral Forms, 2022-2032F

6.2.5 Australia Corticosteroid Market Revenues & Volume, By Systemic Forms, 2022-2032F

6.2.6 Australia Corticosteroid Market Revenues & Volume, By Others, 2022-2032F

6.3 Australia Corticosteroid Market, By Application

6.3.1 Overview and Analysis

6.3.2 Australia Corticosteroid Market Revenues & Volume, By Rheumatology Indications, 2022-2032F

6.3.3 Australia Corticosteroid Market Revenues & Volume, By Skin Allergies, 2022-2032F

6.3.4 Australia Corticosteroid Market Revenues & Volume, By Endocrinology, 2022-2032F

6.3.5 Australia Corticosteroid Market Revenues & Volume, By Gastroenterology, 2022-2032F

6.3.6 Australia Corticosteroid Market Revenues & Volume, By Acute Respiratory Diseases, 2022-2032F

6.3.7 Australia Corticosteroid Market Revenues & Volume, By Others, 2022-2032F

7 Australia Corticosteroid Market Import-Export Trade Statistics

7.1 Australia Corticosteroid Market Export to Major Countries

7.2 Australia Corticosteroid Market Imports from Major Countries

8 Australia Corticosteroid Market Key Performance Indicators

8.1 Prescription rates of corticosteroids by healthcare professionals

8.2 Patient adherence and compliance rates to corticosteroid treatment regimens

8.3 Rate of adverse events reported related to corticosteroid use

8.4 Number of clinical trials and research studies on new corticosteroid formulations or applications

8.5 Patient satisfaction scores and feedback on corticosteroid treatments

9 Australia Corticosteroid Market - Opportunity Assessment

9.1 Australia Corticosteroid Market Opportunity Assessment, By Product, 2022 & 2032F

9.2 Australia Corticosteroid Market Opportunity Assessment, By Administration, 2022 & 2032F

9.3 Australia Corticosteroid Market Opportunity Assessment, By Application, 2022 & 2032F

10 Australia Corticosteroid Market - Competitive Landscape

10.1 Australia Corticosteroid Market Revenue Share, By Companies, 2032

10.2 Australia Corticosteroid Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence